CompletedPhase 1NCT02737371

Multiple Ascending Oral Dose Study of F901318 in Healthy Subjects

Studying Aspergillosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
F2G Biotech GmbH
Principal Investigator
Girish Sharma, MD
Simbec Research
Intervention
F901318 Dose level A oral(drug)
Enrollment
40 enrolled
Eligibility
18-45 years · All sexes
Timeline
2016 – 2017

Study locations (1)

Collaborators

SimbecRresearch Ltd.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02737371 on ClinicalTrials.gov

Other trials for Aspergillosis

Additional recruiting or active studies for the same condition.

See all trials for Aspergillosis →

← Back to all trials